158 related articles for article (PubMed ID: 37462300)
21. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis.
Thiele Orberg E; Fan H; Tam AJ; Dejea CM; Destefano Shields CE; Wu S; Chung L; Finard BB; Wu X; Fathi P; Ganguly S; Fu J; Pardoll DM; Sears CL; Housseau F
Mucosal Immunol; 2017 Mar; 10(2):421-433. PubMed ID: 27301879
[TBL] [Abstract][Full Text] [Related]
22. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
23. A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer.
Scott N; Whittle E; Jeraldo P; Chia N
Neoplasia; 2022 Jul; 29():100797. PubMed ID: 35461079
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer.
Kurt M; Yumuk Z
Sci Rep; 2021 Jan; 11(1):1608. PubMed ID: 33452405
[TBL] [Abstract][Full Text] [Related]
25. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
26. RETRACTED: Comparison between diagnostic performance of intestinal Fusobacterium nucleatum, Bacteroides fragilis and Escherichia coli in 5-fluorouracil resistance to colorectal cancer: A meta‑analysis.
Wang WY; Zhou H; Wang Z; Zhang YH
Cancer Treat Res Commun; 2022; 32():100536. PubMed ID: 35567912
[TBL] [Abstract][Full Text] [Related]
27. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
28. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471
[TBL] [Abstract][Full Text] [Related]
29. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
[TBL] [Abstract][Full Text] [Related]
30. Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort.
Gong D; Adomako-Bonsu AG; Wang M; Li J
PeerJ; 2023; 11():e15777. PubMed ID: 37554340
[TBL] [Abstract][Full Text] [Related]
31. Entero-toxigenic
Yang J; Wang X; Hu T; Huang H; Chen G; Jin B; Zeng G; Liu J
Cell Cycle; 2024 Jan; 23(1):70-82. PubMed ID: 38273425
[TBL] [Abstract][Full Text] [Related]
32. [Expression of enterotoxigenic Bacteroides fragilis and polyketide synthase gene-expressing Escherichia coli in colorectal adenoma patients].
Xie LL; Wu N; Zhu YM; Qiu XY; Chen GD; Zhang LM; Liu YL
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(12):954-9. PubMed ID: 27045721
[TBL] [Abstract][Full Text] [Related]
33. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer.
Matsumiya Y; Suenaga M; Ishikawa T; Kudo T; Nakagawa T; Okamoto K; Tokunaga M; Hurtado C; Yamada Y; Oka K; Takahashi M; Lopez Kostner LF; O'Ryan Gallardo ML; Uetake H; Kinugasa Y
Anaerobe; 2023 Dec; 84():102784. PubMed ID: 37806638
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway.
Bao Y; Tang J; Qian Y; Sun T; Chen H; Chen Z; Sun D; Zhong M; Chen H; Hong J; Chen Y; Fang JY
Cell Death Dis; 2019 Sep; 10(9):675. PubMed ID: 31515468
[TBL] [Abstract][Full Text] [Related]
36. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
37.
Brennan CA; Clay SL; Lavoie SL; Bae S; Lang JK; Fonseca-Pereira D; Rosinski KG; Ou N; Glickman JN; Garrett WS
Gut Microbes; 2021; 13(1):1987780. PubMed ID: 34781821
[TBL] [Abstract][Full Text] [Related]
38. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
[TBL] [Abstract][Full Text] [Related]
39. Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming.
Jones J; Shi Q; Nath RR; Brito IL
PLoS One; 2024; 19(2):e0297897. PubMed ID: 38363784
[TBL] [Abstract][Full Text] [Related]
40. Fecal detection of enterotoxigenic Bacteroides fragilis.
Chen LA; Van Meerbeke S; Albesiano E; Goodwin A; Wu S; Yu H; Carroll K; Sears C
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1871-7. PubMed ID: 26173688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
